fritsfranssen Profile Banner
Frits Franssen Profile
Frits Franssen

@fritsfranssen

Followers
5K
Following
1K
Media
2K
Statuses
4K

Head of department of Respiratory Medicine, Maastricht University Medical Centre, the Netherlands / Fellow of ERS

Maastricht
Joined September 2010
Don't wanna be here? Send us removal request.
@fritsfranssen
Frits Franssen
9 days
Multiple direct and indirect pathways increase risk of lung disease exacerbations during heat waves. Community preparedness and advocacy are needed, particularly to address greater adverse effects on vulnerable populations.
Tweet media one
0
7
10
@fritsfranssen
Frits Franssen
13 days
New US study shows that COPD confers a 1.9-fold higher risk of intensive care unit admission or in-hospital mortality in adults hospitalized with RSV #virus #RSV
Tweet media one
0
7
21
@fritsfranssen
Frits Franssen
20 days
COPD patient survey shows that >20% of patients are not on maintenance therapy; leading reasons include that their COPD was not severe enough, and that their doctors had not recommended it. Action is needed for more effective and timely disease management. @COPDFoundation
Tweet media one
1
5
21
@fritsfranssen
Frits Franssen
3 months
Airway mucus plugs were previously associated with increased risk of exacerbations and mortality in COPD. Now, persistent and newly formed mucus plugs.are associated with a faster decrease in lung function (FEV1) in this disease. @NEJM
Tweet media one
2
15
39
@fritsfranssen
Frits Franssen
3 months
Newly proposed diagnostic schema for COPD using major and minor criteria classifies individuals as having this disease beyond airflow limitation and identifies individuals at increased risk for poor outcomes. doi:10.1001/jama.2025.7358 @JAMA_current
Tweet media one
2
33
77
@fritsfranssen
Frits Franssen
5 months
Pulmonary rehabilitation is an evidence-based, personalized, comprehensive intervention that improves physical and psychological function and reduces healthcare consumption in people with chronic respiratory conditions #PRweek2025 #COPD
Tweet media one
0
5
15
@fritsfranssen
Frits Franssen
6 months
Almost 31% of persons hospitalized with severe RSV infection has underlying COPD and in-hospital mortality in this group may be as high as 18%. Preventive vaccins are available but need to be implemented.
Tweet media one
0
0
2
@fritsfranssen
Frits Franssen
6 months
Targeting T2 inflammation or epithelial-derived alarmins represents a step forward in precision medicine for the treatment of a subset of COPD.
Tweet media one
1
10
21
@fritsfranssen
Frits Franssen
6 months
Theoretical framework illustrating the potential impact of body composition on COPD exacerbation risk; from our latest editorial in @RespirologyAPSR @Machado_FVC
Tweet media one
0
7
18
@fritsfranssen
Frits Franssen
6 months
Hard to comprehend and even harder to accept: a 46.3%, or 35 year (!), loss of life expectancy in the Gaza Strip during the period October, 2023, to September, 2024. Touched by this @TheLancet paper.
Tweet media one
1
4
7
@fritsfranssen
Frits Franssen
6 months
New meta-analysis shows a significant 20% reduction in all-cause mortality with ICS-containing therapies versus non-ICS containing inhaler therapies in COPD. Future research should identify patient subgroups most likely to benefit while minimizing adverse effects.
Tweet media one
1
12
18
@fritsfranssen
Frits Franssen
6 months
The worldwide prevalence of shortness of breath in adults is approx. 14%, with a wide variation across sites. Furthermore, it is strongly associated with spirometric obstruction and restriction. #BOLD
Tweet media one
0
0
1
@fritsfranssen
Frits Franssen
7 months
PDE3 and PDE4 contribute to inflammation and airway smooth muscle contraction, that is evident in conditions such as COPD. Dual inhibition of these enzymes may provide clinical benefit to a broad range of patients with COPD and represents a promising new treatment strategy.
Tweet media one
0
5
15
@fritsfranssen
Frits Franssen
7 months
Proposal for the management of cardiovascular risk factors and disease in patients with COPD
Tweet media one
0
9
28
@fritsfranssen
Frits Franssen
8 months
Epidemiological study reports no association between inhaled corticosteroid (ICS) and risk of major adverse cardiovascular events (except heart failure) in COPD. Thus, potential ICS-related cardioprotection remains to be established. @ThoraxBMJ Inhaled corticosteroids and major
Tweet media one
0
6
11
@fritsfranssen
Frits Franssen
8 months
Impact of home non-invasive ventilation in chronic hypercapnic respiratory failure due to COPD. Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how? - PubMed (
Tweet media one
1
16
18
@fritsfranssen
Frits Franssen
8 months
Patient-reported outcome measures (PROMs) are poorly related to clinical measures in severe asthma, but PROMs are prone to changes in usual care, with exacerbations playing a key role. #asthma
Tweet media one
0
3
4
@fritsfranssen
Frits Franssen
8 months
Our latest study is now online in @JAMANetworkOpen, reporting on the limited estimative performance of exacerbation (ECOPD) history categories by GOLD. Novel cutoffs based on a history of 1 or more moderate ECOPD, 1 or more severe ECOPD, or both within 12 months are suggested.
Tweet media one
0
5
15
@fritsfranssen
Frits Franssen
8 months
Low birth weight is associated with increased risk of COPD, but also has interactions with maternal smoking, older age and passive smoking. Low birth weight and smoking during pregnancy have a joint effect.
Tweet media one
0
6
21